Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Boston Scientific

company

About

Boston Scientific is an innovator of medical solutions that improve patient health.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$2B
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 1979
Number Of Employee
10001 - max
Operating Status
Active
Stock Symbol
nyse:BSX
Legal Name
Boston Scientific Corporation

Boston Scientific is an innovator of medical solutions that improve the health of patients around the world. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies, and services across a wide range of medical specialties. These less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems. Boston Scientific continues to innovate in these areas and is extending its innovations into new geographies and high-growth adjacency markets. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific acts with integrity and compassion to support patients, customers, our communities, and each other.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$3B €3B
Boston Scientific has raised a total of $3B €3B in funding over 2 rounds. Their latest funding was raised on Mar 4, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 4, 2022 Post-IPO Debt €3B Detail
May 21, 2020 Post-IPO Equity $2B Detail
Feb 27, 2018 Post-IPO Debt $1B Detail
May 29, 1992 IPO Detail

Investments

Number of Investments
Number of Lead Investments
82
18
Boston Scientific has made 82 investments. Their most recent investment was on Jan 19, 2023, when SetPoint Medical raised $80M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 19, 2023 SetPoint Medical
Series Unknown $80M Biotechnology
Dec 8, 2022 Shibuya
Seed $6.90M Blockchain
Jun 9, 2022 Request Finance
Seed $5.50M Accounting
Mar 17, 2022 LAGO
Pre-seed $4.20M Art
Feb 8, 2022 Rift Finance
Series Unknown $18M Blockchain

Employee Profiles

Number of Employee Profiles
55
Boston Scientific has 55 current employee profiles, including Advisor Kevin Makati
Advisor
Board member
Executive
Employee
Executive

Exits

Boston Scientific has had 18 exits. Boston Scientific most notable exits include Broncus Technologies ,   RenovoRx

Date Company Name Exit Type Industry
Sep 24, 2021 Broncus Technologies IPO Biotechnology Detail
Aug 25, 2021 RenovoRx IPO Biotechnology Detail
Jan 21, 2021 Preventice Solutions M&A Health Care Detail
Sep 30, 2020 Pulmonx IPO Health Care Detail
Jul 9, 2018 TVA Medical M&A Health Care Detail

Acquisition

Boston Scientific has acquired 54 organizations. Their most recent acquisition was Boston Scientific Scimed on Nov 9, 1994. They acquired Boston Scientific Scimed for 0.

Date Company Name
Industry Acquisition Type Price
Health Care acquisition Detail
Jan 22, 1996 EP Technologies
Health Care acquisition Detail
Fitness acquisition Detail
Health Care acquisition $ 75M Detail
Health Care acquisition Detail